Sep 13, 2023
Join us on the latest episode! Our Guest: Javier Swarcberg, CEO of Spruce Biosciences
What you'll get out of this episode:
Dive deep into the world of Congenital Adrenal Hyperplasia (CAH) treatments and drug development.
Understand the challenges and rewards of addressing rare diseases, especially in pediatrics.
Javier Szwarcberg discusses Spruce's innovative Tildesophon and its potential impact on the CAH therapeutic landscape.
Discover the upcoming clinical updates from Spruce Biosciences and the promising future outlook for CH treatments.
To learn more about Spruce Biosciences: https://sprucebio.com/
Our sponsors for this episode are:Sage Growth Partners https://sage-growth.com/
Slice of Healthcare
Oct 21, 2026
Oct 7, 2026
Sep 30, 2026
Sep 3, 2026
Aug 26, 2026
Aug 5, 2026
Jul 29, 2026
Jul 22, 2026
Jul 8, 2026
Jun 24, 2026